Table 3:

Adverse events within 30 postoperative days

	Overall-44, N (%)	Simultaneous-5, N (%)	Staged-19, N (%)	P-value
Cardiac adverse events	2 (5)	0 (0)	2 (11)	0.18
Cerebrovascular adverse events	2 (5)	1 (4)	1 (5)	1
Gastrointestinal adverse events	0 (0)	0 (0)	0 (0)	–
Renal function worsening	5 (11)	2 (8)	3 (16)	0.64
Dialysis	0	0	0	–
Pulmonary adverse events	5 (11)	0 (0)	5 (26)	0.01
Need of postoperative cardiac pacemaker	9 (21)	2 (8)	7 (37)	0.02
Reinterventions	1 (2)	0 (0)	1 (5)	0.43
Vascular access complication	2 (5)	1 (4)	1 (5)	1
Death	1 (2)	0 (0)	1 (5)	0.43

Among the 5 cases of renal function worsening reported at 24 postoperative days, 2 returned to baseline value within 30 days.

N: numbers.